Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$3.07 USD
-0.05 (-1.60%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $3.06 -0.01 (-0.33%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CLOV 3.07 -0.05(-1.60%)
Will CLOV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CLOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLOV
Here's Why You Should Add CLOV Stock to Your Portfolio Now
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
CLOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
Other News for CLOV
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting
CLOV forms NR7 on September 16
Clover Health (CLOV) Boosts Efficiency with Availity Partnership
Clover Health launches Availity Essentials portal
Clover Health launches Availity Essentials portal